This inventor holds 1 USPTO granted patent. Top assignees: Brock University, University of Pittsburgh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 27 
1 out of 1,959 
Years Active: 2016
Title: Valarian E Kagan: Innovator in Mitochondrial Research
Introduction
Valarian E Kagan is a notable inventor based in Pittsburgh, PA, recognized for his contributions to mitochondrial research. He holds a patent that focuses on innovative approaches to prevent apoptosis, a critical process in cellular health.
Latest Patents
Kagan's most recent patent is titled "Mitochondria-targeted inhibitors of cytochrome c peroxidase for protection from apoptosis." This patent describes novel imidazole-substituted fatty acids that have been functionalized with an alkyl triphenylphosphonium group. The compositions comprising these compounds are designed to act as inhibitors of cytochrome c peroxidase, specifically for the treatment and prevention of apoptosis.
Career Highlights
Throughout his career, Kagan has worked with prestigious institutions, including the University of Pittsburgh and Brock University. His research has significantly advanced the understanding of mitochondrial functions and their implications in cell survival.
Collaborations
Kagan has collaborated with notable colleagues, including Jeffrey Atkinson and Jeffrey Stuart, contributing to a rich environment of innovation and research.
Conclusion
Valarian E Kagan's work in mitochondrial research and his patented innovations highlight his significant impact in the field of cellular biology. His contributions continue to pave the way for advancements in the treatment of apoptosis-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile